New York State Teachers Retirement System grew its stake in Kenvue Inc. (NYSE:KVUE - Free Report) by 3.7% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,562,421 shares of the company's stock after buying an additional 56,078 shares during the period. New York State Teachers Retirement System owned 0.08% of Kenvue worth $33,358,000 as of its most recent filing with the Securities and Exchange Commission.
Other hedge funds also recently made changes to their positions in the company. Asset Planning Inc acquired a new stake in shares of Kenvue during the fourth quarter worth $42,000. White Pine Capital LLC grew its holdings in Kenvue by 1.0% during the 4th quarter. White Pine Capital LLC now owns 54,572 shares of the company's stock worth $1,165,000 after acquiring an additional 542 shares during the period. Vontobel Holding Ltd. raised its position in shares of Kenvue by 38.7% in the 4th quarter. Vontobel Holding Ltd. now owns 31,335 shares of the company's stock worth $669,000 after acquiring an additional 8,741 shares in the last quarter. Asset Management One Co. Ltd. lifted its stake in shares of Kenvue by 3.0% in the 4th quarter. Asset Management One Co. Ltd. now owns 749,580 shares of the company's stock valued at $16,138,000 after purchasing an additional 21,545 shares during the period. Finally, Pathway Financial Advisers LLC lifted its stake in shares of Kenvue by 19.1% in the 4th quarter. Pathway Financial Advisers LLC now owns 12,697 shares of the company's stock valued at $271,000 after purchasing an additional 2,040 shares during the period. 97.64% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
A number of brokerages have weighed in on KVUE. Barclays lowered their target price on Kenvue from $23.00 to $21.00 and set an "equal weight" rating for the company in a report on Friday, January 17th. Bank of America increased their target price on shares of Kenvue from $24.00 to $27.00 and gave the stock a "buy" rating in a research note on Tuesday, October 22nd. Royal Bank of Canada reaffirmed a "sector perform" rating and issued a $24.00 price target on shares of Kenvue in a research note on Monday, February 3rd. Citigroup cut their price objective on shares of Kenvue from $25.00 to $21.00 and set a "neutral" rating on the stock in a research report on Wednesday, January 15th. Finally, Canaccord Genuity Group decreased their target price on Kenvue from $27.00 to $24.00 and set a "buy" rating for the company in a research report on Friday, February 7th. One research analyst has rated the stock with a sell rating, eight have assigned a hold rating and five have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $23.00.
Get Our Latest Stock Analysis on KVUE
Kenvue Stock Up 1.2 %
Shares of NYSE:KVUE traded up $0.26 during mid-day trading on Wednesday, hitting $22.26. 14,194,931 shares of the company traded hands, compared to its average volume of 13,257,708. The stock has a 50-day moving average price of $21.30 and a two-hundred day moving average price of $22.12. Kenvue Inc. has a 12-month low of $17.67 and a 12-month high of $24.46. The stock has a market cap of $42.68 billion, a P/E ratio of 42.00, a P/E/G ratio of 2.57 and a beta of 1.45. The company has a current ratio of 1.00, a quick ratio of 0.69 and a debt-to-equity ratio of 0.66.
Kenvue (NYSE:KVUE - Get Free Report) last posted its quarterly earnings data on Thursday, February 6th. The company reported $0.26 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.26. Kenvue had a net margin of 6.66% and a return on equity of 20.97%. On average, equities research analysts forecast that Kenvue Inc. will post 1.14 earnings per share for the current year.
Kenvue Announces Dividend
The firm also recently declared a quarterly dividend, which will be paid on Wednesday, February 26th. Investors of record on Wednesday, February 12th will be given a dividend of $0.205 per share. This represents a $0.82 dividend on an annualized basis and a dividend yield of 3.68%. The ex-dividend date is Wednesday, February 12th. Kenvue's payout ratio is 154.72%.
About Kenvue
(
Free Report)
Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.
Featured Articles
Before you consider Kenvue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Kenvue wasn't on the list.
While Kenvue currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Which stocks are likely to thrive in today's challenging market? Enter your email address and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
